Cargando...
Development and validation of a LC–MS/MS method for quantification of hetrombopag for pharmacokinetics study
Hetrombopag as the derivative of ethylidene hydrazine carboxamide was recently developed into a novel patented non-peptide thrombopoietin mimetic and thrombopoietin receptor agonist to treat idiopathic thrombocytopenic purpura. To study the pharmacokinetics of hetrombopag, a highly sensitive, rapid...
Guardado en:
| Publicado en: | Springerplus |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Springer International Publishing
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4628022/ https://ncbi.nlm.nih.gov/pubmed/26543786 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40064-015-1446-0 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|